Urokinase for Injection 500,000 IU manufacturer in India Taj Pharmaceuticals best quality supplier

Page 1

Taj Pharmaceuticals as Manufacturer of Urokinase for Injection 500,000 IU Urokinase for Injection 500,000 IU manufacturer in India {Taj Pharmaceuticals}; best quality supplier and exporter of Urokinase for Injection 500,000 IU Taj Pharmaceuticals manufactures a wide range of pharmaceuticals formulation involving // and Orals. Taj Pharma India team has an excellent expertise in manufacturing and export of Urokinase for Injection 500,000 IU Taj Pharmaceuticals places its main business as a Pharmaceuticals manufacturing and exports of generic drug supply of Urokinase for Injection 500,000 IU; primarily of pharmaceuticals preparations known as Urokinase for Injection 500,000 IU; as well as more than 100+ generic equivalent drug. Taj Pharmaceuticals has performed these business activities related to exports of Urokinase for Injection 500,000 IU for major foreign-affiliated pharmaceutical import companies, ministry of health, tenders etc. and have enjoyed the full confidence of these companies, instructions and governments. Taj Pharma Group Under close cooperation between the formulation manufacturing division, active ingredient division and the technology development division for major generic formulations such as Urokinase for Injection 500,000 IU; at Taj Pharma we will appropriately meet diverse needs for Urokinase for Injection 500,000 IU export manufacturing in a wide range of activities from investigation of possible formulations of Urokinase for Injection 500,000 IU, formulation development, making applications to the international regulatory authorities for marketing approval, validation of Urokinase for Injection 500,000 IU through to manufacturing scale production at our cGMP compliant manufacturing units of Taj Pharmaceuticals under the umbrella of Taj Pharma Group. We at Taj Pharma intend to make our manufacturing systems comply with the requirements of the FDA (cGMP) such that pilot plant scale production of products in the stage of clinical development or for use in clinical studies, as well as manufacture of products in small lots are practicable to ensure a highly stable pharmaceuticals formulations of generic equivalent and bio-similar products. We conduct extensive bio-similar and bio-equivalency studies for all our formations in order to obtain better shelf life, absorption and excellent quality of our generic formulation.


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.